These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Phenytoin desensitization in a child with symptomatic localization-related epilepsy. Itomi S; Okumura A; Ikuta T; Negoro T; Watanabe K Brain Dev; 2007 Mar; 29(2):121-3. PubMed ID: 16935446 [TBL] [Abstract][Full Text] [Related]
5. Appropriateness of intravenous loading dose of phenytoin treatment in Srinagarind Hospital. Tiamkao S; Chitravas N; Jitpimolmard S; Sawanyawisuth K J Med Assoc Thai; 2005 Nov; 88(11):1638-41. PubMed ID: 16471113 [TBL] [Abstract][Full Text] [Related]
6. Phenytoin-induced hyperglycemia. Carter BL; Small RE; Mandel MD; Starkman MT Am J Hosp Pharm; 1981 Oct; 38(10):1508-12. PubMed ID: 7294047 [TBL] [Abstract][Full Text] [Related]
7. [Cross-hypersensitivity syndrome between antiepileptic drugs: report of a case]. Allende Bandrés MA; Izuel Rami M; Urbieta Sanz E; Villar Fernández I; Carcelén Andrés J Farm Hosp; 2004; 28(1):56-8. PubMed ID: 15012179 [TBL] [Abstract][Full Text] [Related]
8. Phenytoin induced dyskinesia. Chaudhary N; Ravat SH; Shah PU Indian Pediatr; 1998 Mar; 35(3):274-6. PubMed ID: 9707885 [No Abstract] [Full Text] [Related]
9. Paradoxical seizures in phenytoin toxicity. Chua HC; Venketasubramanian N; Tan CB; Tjia H Singapore Med J; 1999 Apr; 40(4):276-7. PubMed ID: 10487084 [TBL] [Abstract][Full Text] [Related]
10. Vestibular and hearing manifestations of phenytoin toxicity: a retrospective series. De Diego JI; Prim MP; Marcos S; De Sarria MJ; Arpa J; Gavilan J Ear Nose Throat J; 2001 Jun; 80(6):404, 407-9. PubMed ID: 11433844 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of phenytoin against hyponatremic seizures due to SIADH after administration of anticancer drugs in a neonate. Okamoto M; Nako Y; Tachibana A; Fujiu T; Ohki Y; Tomomasa T; Morikawa A J Perinatol; 2002; 22(3):247-8. PubMed ID: 11948390 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study. Ebid AH; Ahmed MM; Mohammed SA Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887 [TBL] [Abstract][Full Text] [Related]
15. [Calculating how long phenytoin intoxication lasts]. Sánchez-Romero A; Durán-Ferreras E; Espigares-Jiménez M; Durán-Quintana JA Rev Neurol; 2003 Sep 16-30; 37(6):539-40. PubMed ID: 14533073 [TBL] [Abstract][Full Text] [Related]
16. Transient phenytoin induced IgA deficiency and permanent IgE increase. Blanco A; Palencia R; Solis P; Arranz E; Sánchez Villares E Allergol Immunopathol (Madr); 1986; 14(6):535-8. PubMed ID: 3030084 [TBL] [Abstract][Full Text] [Related]
17. Dosing and therapeutic monitoring of phenytoin in young adults after neurotrauma: are current practices relevant? Frend V; Chetty M Clin Neuropharmacol; 2007; 30(6):362-9. PubMed ID: 18090462 [TBL] [Abstract][Full Text] [Related]
18. [Acute liver failure by diphenylhydantoin]. Bosia JD; Borzi S; Cocozzella D; Corallini O; Mayet M; Malca M; Padrone M; Rivero A; Cecchi G; Fraquelli E; Curciarello JO Acta Gastroenterol Latinoam; 2000; 30(2):73-6. PubMed ID: 10925722 [TBL] [Abstract][Full Text] [Related]
19. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability. Iivanainen M J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428 [TBL] [Abstract][Full Text] [Related]